Ocuphire Pharma Operating Income 2010-2024 | IRD
Ocuphire Pharma operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Ocuphire Pharma Annual Operating Income (Millions of US $) |
2023 |
$-11 |
2022 |
$18 |
2021 |
$-23 |
2020 |
$-20 |
2019 |
$-4 |
2018 |
$-21 |
2017 |
$-17 |
2016 |
$-16 |
2015 |
$-18 |
2014 |
$-13 |
2013 |
$-8 |
2012 |
$-7 |
2011 |
$-16 |
2010 |
$-10 |
2009 |
$-6 |
Ocuphire Pharma Quarterly Operating Income (Millions of US $) |
2024-06-30 |
$-8 |
2024-03-31 |
$-8 |
2023-12-31 |
$-5 |
2023-09-30 |
$6 |
2023-06-30 |
$-5 |
2023-03-31 |
$-6 |
2022-12-31 |
$-6 |
2022-09-30 |
$-5 |
2022-06-30 |
$-5 |
2022-03-31 |
$-7 |
2021-12-31 |
$-6 |
2021-09-30 |
$-4 |
2021-06-30 |
$-7 |
2021-03-31 |
$-5 |
2020-12-31 |
$-14 |
2020-09-30 |
$-2 |
2020-06-30 |
$-1 |
2020-03-31 |
$-3 |
2019-12-31 |
$5 |
2019-09-30 |
$-2 |
2019-06-30 |
$-3 |
2019-03-31 |
$-4 |
2018-12-31 |
$-5 |
2018-09-30 |
$-5 |
2018-06-30 |
$-5 |
2018-03-31 |
$-6 |
2017-12-31 |
$-5 |
2017-09-30 |
$-4 |
2017-06-30 |
$-4 |
2017-03-31 |
$-4 |
2016-12-31 |
$-4 |
2016-09-30 |
$-4 |
2016-06-30 |
$-4 |
2016-03-31 |
$-5 |
2015-12-31 |
$-4 |
2015-09-30 |
$-5 |
2015-06-30 |
$-5 |
2015-03-31 |
$-4 |
2014-12-31 |
$-4 |
2014-09-30 |
$-3 |
2014-06-30 |
$-4 |
2014-03-31 |
$-3 |
2013-12-31 |
$-2 |
2013-09-30 |
$-2 |
2013-06-30 |
$-2 |
2013-03-31 |
$-2 |
2012-12-31 |
$-1 |
2012-09-30 |
$-2 |
2012-06-30 |
$-2 |
2012-03-31 |
$-2 |
2011-12-31 |
$-2 |
2011-09-30 |
$-3 |
2011-06-30 |
$-6 |
2011-03-31 |
$-4 |
2010-12-31 |
$-3 |
2010-09-30 |
$-2 |
2010-06-30 |
$-3 |
2010-03-31 |
$-2 |
2009-12-31 |
$-2 |
2009-09-30 |
$-1 |
2009-06-30 |
$-2 |
2009-03-31 |
$-1 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.031B |
$0.019B |
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|